Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial-Reference-Cited by-同舟云学术

Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial

Published:2021-04-21 Issue:6 Volume:44 Page:1353-1360
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:Dia Care

Author:

Giugliano Dario^ORCID,Longo Miriam,Caruso Paola,Di Fraia Rosa,Scappaticcio Lorenzo,Gicchino Maurizio,Petrizzo Michela,Bellastella Giuseppe^ORCID,Maiorino Maria Ida^ORCID,Esposito Katherine

Funder

Associazione “Salute con Stile”

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference24 articles.

1. International Diabetes Federation . IDF Diabetes Atlas, 9th edition, 2019. Accessed 30 December 2020. Available from https://www.diabetesatlas.org

2. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study

3. Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006–2013

4. Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes

5. Efficacy of Insulin Analogs in Achieving the Hemoglobin A1c Target of <7% in Type 2 Diabetes

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semaglutide for the management of diabesity: The real-world experience;World Journal of Methodology;2024-09-20

2. Inpatient diabetes management;Annals of the New York Academy of Sciences;2024-07-25

3. Patient-important outcomes in type 2 diabetes: The paradigm of the sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists;Diabetes and Vascular Disease Research;2024-07

4. Expert Opinion on Optimising Type 2 Diabetes Treatment Using Fixed-Ratio Combination of Basal Insulin and GLP-1 RA for Treatment Intensification and Simplification;Diabetes Therapy;2024-06-27

5. Dapagliflozin-Saxagliptin Combination - The Quest for Optimal Glycemic Control With Cardio-Renal Protection in Type 2 Diabetes Mellitus: An Expert Consensus in Indian Settings;Journal of Endocrinology and Metabolism;2024-06